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Abstract
Background: MitraClip implantation is a valid interventional option that offers acceptable short-term results.
Surgery after failed MitraClip procedures remains challenging in high-risk patients. The data on these cases are
limited by the small sample numbers.
Aim: The aim of our study is to show, that mitral valve surgery could be possible and more advantageous, even in
high-risk patients.
Methods: Between 2010 and 2016, nine patients underwent mitral valve surgery after failed MitraClip therapy at
our institution.
Results: The patients’ ages ranged from 19 to 75 years (mean: 61.2 ± 19.6 years). The median interval between the
MitraClip intervention and surgical revision was 45 days (range: 0 to 1087 days). In eight of nine patients, the MitraClip
intervention was initially successful and the mitral regurgitation was reduced. Only one patient had undergone cardiac
surgery previously.
Intra-operatively, leaflet perforation or rupture, MitraClip detachment, and chordal or papillary muscle rupture were
potentially the causes of recurrent mitral regurgitation.
There were three early deaths. One year after surgery, the six remaining patients were alive.
Conclusions: Mitral valve surgery can be successfully performed after failed MitraClip therapy in high-risk patients. The
initial indication for MitraClip therapy should be considered carefully for possible surgical repair.
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Background
Mitral valve repair is the gold standard of treatment for
mitral regurgitation [1, 2]. The surgery can be performed
through conventional sternotomy or right anterolateral
mini-thoracotomy with an excellent long-term outcome
and high repair rates [3, 4]. In 2007, the percutaneous
mitral valve repair via the MitraClip system was intro-
duced in clinical use for high-risk surgical patients [5, 6].
In these high-risk patients, percutaneous mitral valve
intervention showed effective reduction of mitral regur-
gitation [7]. Several studies reported good short-term
results after mitral clipping, while others compared mi-
tral valve surgery with MitraClip procedures. The results
showed comparable outcomes, as well as significant
differences in early mortality and the prevalence of
serious adverse events [8–10]. In the literature, there are
only few case reports and case series on surgical revision
after MitraClip therapy with successful short-term re-
sults. In most cases, surgical therapy was successful
despite a partially complicated and prolonged clinical
course [1, 5, 11–13].
We present a report of nine patients who underwent
mitral valve surgery after MitraClip therapy.
Patients
Patients’ characteristics
Between 2010 and 2016, nine patients underwent mitral
clipping at our hospital’s Department of Cardiology and
were admitted to our Cardiac Surgery Department
owing to indications of recurrent mitral regurgitation
and hemodynamic instability with cardiogenic shock or
cardiac arrest. Six patients had poor ejection fraction
(EF) ≤ 30% and only one patient had already undergone
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previous cardiac surgery. All patients had histories of
cardiac decompensation. At the time of surgery, six
patients presented in New York Heart Association
(NYHA) Class IV and the surgery was performed as
ultimate ratio in these cases. Four patients suffered from
chronic kidney disease without any need for dialysis.
Dilated cardiomyopathy (n = 2) and ischemic cardiomy-
opathy (n = 3) were present in our cohort. One patient
suffered from congenital mitral valve malformation and
three other patients had a degenerative mitral valve re-
gurgitation. Two patients were preoperatively ventilated.
Two patients were accepted for surgery in an emergency
situation.
During MitraClip intervention in one of these cases,
the MitraClip catheter became locked in the mitral
position. This resulted in the need for cardiopulmonary
resuscitation and emergent mitral valve surgery was
necessary. Another patient presented with cardiogenic
shock 54 days after successful mitral clipping with mitral
regurgitation (MR) reduction from IV° to III° and had to
undergo emergent surgery. The preoperative conditions
of the patients are summarized in Table 1.
Results
Surgical data
The interval between mitral clipping and surgery ranged
between zero (an emergency case with cardiac arrest) and
1087 days with eight of nine patients presenting within
≤365 days. The operations were performed using
cardiopulmonary bypass through conventional sternotomy
(n = 8) or right mini-thoracotomy (n = 1). The mean by-
pass time was 169.9 ± 36.3min with a mean aortic clamp
time of 99.6 ± 16.9min. In only two patients, mitral valve
repair was possible. They underwent mitral valve ring
anuloplasty. In one case, a posterior leaflet repair in P2/P3
through triangular resection was performed and the
implantation of two neochordae in segment A2/A3 was
necessary. Owing to perforation, leaflet adhesion, and
severe valve damage, mitral valve replacement was neces-
sary in the seven other cases. In three cases, the closure of
an iatrogenic atrial septal defect was performed. Six
patients received concomitant tricuspid valve re-
pair- four through annuloplasty and two through De
Vega plasty. One patient needed coronary revasculariza-
tion. An intra-aortic balloon pump (IABP) implantation
was necessary in one case, and no extracorporeal
membrane oxygenation (ECMO) was needed.
Intra-operatively and postoperatively there was no
paravalvular leakage, and in the repair cohort the mitral
regurgitation (MR) ≤ I° was noted in one case.
Intra-operative findings
We were able to analyze the causes of failed MitraClip
therapy intra-operatively. Severe valve damage caused by
clipping was found in most cases. We found perforation
of the posterior mitral leaflet P2 in two cases. One
patient had perforation in the segment A3/P3, another
had papillary muscle rupture, and in three cases the
MitraClips were detached. Two patients had chordal
rupture. In one of the emergent cases with perforation
of the posterior mitral leaflet P2, the catheter was locked
Table 1 Patients Characteristics
Variable Value (n = 9)
Age [mean ± SD] 61.2 ± 19.6
Sex [No.]
Female 5 (55.6%)
Male 4 (44.4%)
NYHA class
III 6 (66.7%)
IV 3 (33.3%)
Prior cardiac decompensation [No.] 9 (100%)
Diabetes mellitus 6 (66.7%)
Hypertension 7 (77.8%)
Smoking 5 (55.6%)
Atrial fibrillation 8 (88.9%)
Hyperlipidemia 5 (55.6%)
Prior cardiac surgery 1 (11.1%)
Time since mitral clipping [median, days] 45
Emergency surgery [No.] 2 (22.2%)
Cardiogenic shock 1 (11.1%)
Cardiac arrest with CPR 1 (11.1%)
Etiology of mitral regurgitation
ischemic cardiomyopathy 3 (33.3%)
Congenital mitral valve malformation 1 (11.1%)
Dilated cardiomyopathy 2 (22.2%)
Degenerative, ring dilatation 2 (22.2%)
Degenerative, prolapse of anterior leaflet 1 (11.1%)
Numbers of implanted MitraClips [No.]
1 5
2 4
Ejection fraction [No.]
< 30% 6
30–50% 0
> 50% 3
Coronary artery disease [No.] 8 (88.9%)
Prior PTCA ± stent 4 (44.4%)
Chronic renal failure 4 (44.4%)
Dialysis 0
History of myocardial infarction [No.] 5 (55.6%)
COPD 2 (22.2%)
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in the mitral position. No patient showed signs of
endocarditis.
Postoperative outcome
There were three in-hospital deaths (on the 6th, 17th,
and 33rd days) after surgery. The patient who presented
with cardiogenic shock preoperatively died on the 33rd
day postoperatively due to multi-organ failure with acute
renal failure, pneumonia, pancreatitis, and bowel ische-
mia resulting in laparotomy with bowel resection. The
second patient died of hypoxemia due to aspiration of
food remains on the 17th day postoperatively after an
initially uneventful clinical course and the third one
suffered from multiple ischemic cerebral infarctions with
severe brain injury. The last one required surgery with
cardiopulmonary resuscitation. Only one patient suffered
from mediastinal bleeding requiring re-thoracotomy. No
myocardial infarction occurred postoperatively. Respira-
tory failure requiring prolonged intubation (> 72 h) and
tracheotomy was observed in two patients. Owing to
atrioventricular block III° in three patients, pacemaker
implantation was necessary. One patient received surgi-
cal revision as a consequence of severe wound infection.
All six survivors were alive at the one-year follow-up.
Discussion
Mitral valve repair remains the treatment of choice in
mitral valve regurgitation [14]. Alfieri et al. demon-
strated the double-orifice technique as a simple tech-
nique for repairing complex mitral valve lesions [15]. A
few years later, a modified interventional technique
based on the Alfieri technique, the MitraClip system,
was introduced in clinical use for surgical high-risk cases
[5, 16]. In the guidelines from 2012, the European
Society of Cardiology and the European Association for
Cardio-Thoracic Surgery recommended mitral clipping
in cases of inoperability or high risk only in patients
who are assessed by a heart team [17]. Comparative
studies showed similar or superior results in a number
of relevant endpoints of outcomes in surgical patients
[10, 16, 18]. Nevertheless, until today, there is a lack of
comparative studies between surgical mitral valve repair
and percutaneuos mitral repair through mitral clipping
with regard to long-term follow-up. Ondrus et al.
compared both procedures in a small number of samples
in a median follow-up time of 1028 days. The mentioned
study presented similar 30-day mortality and the
prevalence of serious adverse events [9]. In another
comparison among octogenarians, Alozie and colleagues
demonstrated better survival after 1 year and good
functional results in the surgical group [18]. In conclu-
sion, the indication for percutaneous mitral valve repair
should be discussed carefully by the heart team, because
the chance of successful surgical repair after failed
intervention drops and the prognosis after surgery may
worsen dramatically. For this reason, MitraClip interven-
tion should not be performed in patients who can
undergo surgery with acceptable surgical risk.
Furthermore, even the term “inoperable patients” needs
discussing, because many cases were able to show that
these inoperable patients could be operated on success-
fully even after failed mitral clipping [1, 12, 13, 19, 20]. A
systemic review of seven studies which included 67
patients showed that the most common indication for
surgical revision was recurrent mitral regurgitation greater
than 2+, and in two studies one-year survival ranging from
68 to 77% was reported [21]. In our cohort, recurrent
mitral regurgitation was also the most frequent indication
for re-intervention. Among our study population, mitral
valve repair was possible in only two cases (22%), and two
of the three patients who died in the postoperative course
were presented in cardiogenic shock or cardiac arrest
prior to the operation. Elhmidi et al. reported a 20%
(n = 4) mitral valve repair rate in a cohort of 25 patients
undergoing surgical revision after a failed MitraClip
procedure. They also showed that patients with cardio-
genic shock are at the highest risk of in-hospital mortality.
Interestingly, Geidel et al. showed that the number of
implanted MitraClips influenced the chance of mitral
repair [19]. It remains unclear in which interval surgical
revision should be performed. Monsefi et al. and Geidel et
al. preferred a short interval between failed interventional
procedures and mitral valve (MV) surgery in order to pre-
vent a new cardiac decompensation [5, 19].
Conclusion
In the course of increasing popularity for interventional
mitral repair, it still remains unclear how many patients
with MR could be treated surgically with comparable
operative risk and good functional results. The analysis
of the current and here mentioned case series showed
that patients who are considered as high-risk before
MitraClip therapy might become suitable surgical candi-
dates for mitral valve surgery. For that reason, we believe
that an initial decision favoring a less invasive approach
should be considered well, because high-risk patients
thereby miss out on the prospect of valve repair.
Our present study had various limitations. The study
is a retrospective analysis of a single center experience
with few cases. Multicenter studies of large numbers are
needed with long-term follow-up because the data on
this topic are limited by case reports and small case
series. We did not report the long-term outcomes.
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